Orthofix Medical (OFIX) vs Utah Medical Products (UTMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Utah Medical Products (UTMD) has outperformed Orthofix Medical (OFIX) over the past year, gaining 26.0% versus a loss of 60.2%. Over five years, UTMD leads with a -42.3% price change compared with -80.6% for OFIX. Orthofix Medical is the larger company by market cap ($247.4 million vs $198.0 million), about 1.2 times the size.
Utah Medical Products pays a dividend yielding 1.78%, while Orthofix Medical does not currently pay one. Utah Medical Products converts more of its revenue into profit, with a net margin of 29.3% versus -11.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OFIX | UTMD |
|---|---|---|
| Share price | $6.07 | $69.49 |
| Market cap | $247.41M | $198.01M |
| 1-day change | -4.26% | -2.07% |
| YTD return | -59.96% | +24.18% |
| 1-year return | -60.22% | +25.98% |
| 5-year return | -80.64% | -42.25% |
| P/E ratio (TTM) | — | 20.81 |
| Forward P/E | 33.72 | — |
| EPS (TTM) | $-1.10 | $3.34 |
| Dividend yield | 0.00% | 1.78% |
| Annual dividend | $0.00 | $1.24 |
| Revenue (latest FY) | $822.31M | $38.52M |
| Revenue growth (YoY) | +2.85% | -5.83% |
| Net income (latest FY) | $-92.19M | $11.29M |
| Gross margin | 68.83% | 57.12% |
| Operating margin | -9.90% | 29.60% |
| Net margin | -11.21% | 29.30% |
| 52-week high | $16.42 | $76.89 |
| 52-week low | $6.04 | $53.80 |
| Distance from 52-week high | -63.03% | -9.62% |
| Analyst consensus | buy | — |
| Avg. price target upside | +64.74% | — |
| Average volume | 481.16K | 33.70K |
| Shares outstanding | 40.76M | 2.85M |
| Employees | 1,605 | 140 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- UTMD has outperformed OFIX by 86.2 percentage points over the past year.
- Utah Medical Products offers a meaningfully higher dividend yield (1.78% vs 0.00%).
- Utah Medical Products is more profitable, keeping 29.3 cents of every revenue dollar as net income versus -11.2 cents for Orthofix Medical.
- Orthofix Medical grew revenue faster in its latest fiscal year (+2.85% vs -5.83%).
About Orthofix Medical
OFIX stock →Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction.
Health Care · Medical/Dental Instruments · 1,605 employees
About Utah Medical Products
UTMD stock →Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally.
Health Care · Medical/Dental Instruments · 140 employees
OFIX vs UTMD FAQ
Which is bigger, Orthofix Medical or Utah Medical Products?
Orthofix Medical (OFIX) is larger, with a market capitalization of $247.41M compared with $198.01M for Utah Medical Products (UTMD).
Which stock has performed better over the past year, OFIX or UTMD?
UTMD returned +25.98% over the past 12 months, compared with -60.22% for OFIX (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Orthofix Medical or Utah Medical Products?
Utah Medical Products pays a dividend yielding 1.78%, while Orthofix Medical does not currently pay a regular dividend.
Are Orthofix Medical and Utah Medical Products in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.